Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H19NO2 |
Molecular Weight | 209.2848 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(C)=C(OC)C=C1CC(C)N
InChI
InChIKey=NTJQREUGJKIARY-UHFFFAOYSA-N
InChI=1S/C12H19NO2/c1-8-5-12(15-4)10(6-9(2)13)7-11(8)14-3/h5,7,9H,6,13H2,1-4H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095200 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2843634 |
PubMed
Title | Date | PubMed |
---|---|---|
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. | 1998 Jul |
|
Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position: effects on 5-HT(2A/2C) receptor affinity. | 2002 Aug 5 |
|
The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM. | 2002 Dec |
|
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats. | 2002 May |
|
Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex. | 2003 Dec |
|
Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD. | 2003 Feb |
|
Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. | 2003 Feb |
|
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. | 2003 Jul |
|
Low doses of non-NMDA glutamate receptor agonists alter neurobehavioural development in the rat. | 2003 Jul-Aug |
|
Functional study of rat 5-HT2A receptors using antisense oligonucleotides. | 2003 Jun |
|
Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control. | 2003 May |
|
Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate. | 2004 Apr 2 |
|
Stimulus effects of three sulfur-containing psychoactive agents. | 2004 Aug |
|
Common drugs of abuse--Part II. | 2004 Spring |
|
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. | 2005 Jan 5 |
|
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. | 2005 Jun |
|
A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. | 2005 Mar 10 |
|
alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats. | 2006 Oct |
|
A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. | 2007 Aug |
|
Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity. | 2007 Jul |
|
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. | 2007 Jun |
|
Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. | 2007 Sep 15 |
|
Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist. | 2008 Aug |
|
First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. | 2008 Dec |
|
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. | 2008 Feb |
|
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. | 2008 Nov |
|
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats. | 2009 Jul |
|
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses. | 2009 Mar |
|
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices. | 2009 Nov |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
PiHKAL
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-2,5-Dimethoxy-4-methylamphetamine
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
||
|
DEA NO. |
7395
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7595
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
DTXSID50860611
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
100000144899
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
26011-50-7
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
SUPERSEDED | |||
|
11145
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
2,5-DIMETHOXY-4-METHYLAMPHETAMINE
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | 2,5-Dimethoxy-4-methylamphetamine (DOM; known on the street as STP, standing for "Serenity, Tranquility, and Peace") is a psychedelic and a substituted amphetamine. It was first synthesized by Alexander Shulgin, and later reported in his book PiHKAL: A Chemical Love Story. DOM is classified as a Schedule I substance in the United States, and is similarly controlled in other parts of the world. Internationally, it is a Schedule I drug under the Convention on Psychotropic Substances.[1] It is generally taken orally. | ||
|
85875
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
UKI9MLD5OI
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
SUB121767
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
15588-95-1
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
DB01528
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | |||
|
m4731
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
18539-33-8
Created by
admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
|
SUPERSEDED |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)